Maria Meszaros

Temesvári Blvd. 62
Szeged, CS 6726, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

The impact of the novel σ1 receptor ligand (S)-L1 on brain endothelial cells and cerebrovascular reactivity challenged by ischemia.

The impact of the novel σ1 receptor ligand (S)-L1 on brain endothelial cells and cerebrovascular reactivity challenged by ischemia.

Journal: European journal of pharmacology

Published: February 13, 2025

Alanine and glutathione targeting of dopamine- or ibuprofen-coupled polypeptide nanocarriers increases both crossing and protective effects on a blood-brain barrier model.

Alanine and glutathione targeting of dopamine- or ibuprofen-coupled polypeptide nanocarriers increases both crossing and protective effects on a blood-brain barrier model.

Journal: Fluids and barriers of the CNS

Published: September 26, 2024

PepH3-modified nanocarriers for delivery of therapeutics across the blood-brain barrier.

PepH3-modified nanocarriers for delivery of therapeutics across the blood-brain barrier.

Journal: Fluids and barriers of the CNS

Published: August 30, 2024

Synergistic induction of blood-brain barrier properties.

Synergistic induction of blood-brain barrier properties.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 15, 2024

Lab-on-a-chip models of the blood-brain barrier: evolution, problems, perspectives.

Lab-on-a-chip models of the blood-brain barrier: evolution, problems, perspectives.

Journal: Lab on a chip

Published: February 14, 2024

Targeting Human Endothelial Cells with Glutathione and Alanine Increases the Crossing of a Polypeptide Nanocarrier through a Blood-Brain Barrier Model and Entry to Human Brain Organoids.

Targeting Human Endothelial Cells with Glutathione and Alanine Increases the Crossing of a Polypeptide Nanocarrier through a Blood-Brain Barrier Model and Entry to Human Brain Organoids.

Journal: Cells

Published: November 24, 2022

Effects of Hydroxypropyl-Beta-Cyclodextrin on Cultured Brain Endothelial Cells.

Effects of Hydroxypropyl-Beta-Cyclodextrin on Cultured Brain Endothelial Cells.

Journal: Molecules (Basel, Switzerland)

Published: September 26, 2022

Distinct Uptake Routes Participate in Silver Nanoparticle Engulfment by Earthworm and Human Immune Cells.

Distinct Uptake Routes Participate in Silver Nanoparticle Engulfment by Earthworm and Human Immune Cells.

Journal: Nanomaterials (Basel, Switzerland)

Published: July 28, 2022

Cellular Therapy Using Epitope-Imprinted Composite Nanoparticles to Remove α-Synuclein from an In Vitro Model.

Cellular Therapy Using Epitope-Imprinted Composite Nanoparticles to Remove α-Synuclein from an In Vitro Model.

Journal: Cells

Published: July 21, 2022

A Triple Combination of Targeting Ligands Increases the Penetration of Nanoparticles across a Blood-Brain Barrier Culture Model.

A Triple Combination of Targeting Ligands Increases the Penetration of Nanoparticles across a Blood-Brain Barrier Culture Model.

Journal: Pharmaceutics

Published: November 23, 2021

In Vitro Comparative Study of Solid Lipid and PLGA Nanoparticles Designed to Facilitate Nose-to-Brain Delivery of Insulin.

In Vitro Comparative Study of Solid Lipid and PLGA Nanoparticles Designed to Facilitate Nose-to-Brain Delivery of Insulin.

Journal: International journal of molecular sciences

Published: November 04, 2021

S1R agonist modulates rat platelet eicosanoid synthesis and aggregation.

S1R agonist modulates rat platelet eicosanoid synthesis and aggregation.

Journal: Platelets

Published: October 26, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026